Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by Institute of Cardiology, Warsaw, Poland.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT01527279
First received: February 2, 2012
Last updated: November 27, 2014
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
No publications provided by Institute of Cardiology, Warsaw, Poland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):